CompletedPhase 4

Biodentine Vital Pulpotomy in Immature Molars

38 participantsStarted 2016-10-01

Plain-language summary

This study aimed to evaluate the clinical and radiographic success of pulpotomy in cariously exposed vital immature first permanent molars using calcium hydroxide and calcium silicate-based material (Biodentine ™). After a 12 months postoperative period, Biodentine ™ proved very useful as a successful pulpotomy agent in young permanent teeth.

Who can participate

Age range6 Years – 9 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Medical history: Healthy children with no physical or mental disorders assured through medical history questioning. * Mandibular vital immature first permanent molar with deep caries. Restorable. No clinical evidence of extensive pulp degeneration or periapical pathology.No radiographic evidence of periapical pathosis or interradicular bone loss, internal/external resorption and pulp calcification. Exclusion Criteria: * 1\. Patients refuse to cooperate. 2. Spontaneous pain or severe pain which doesn't stop with analgesics. 3. Hemorrhage control wasn't achievable at the operative procedures

What they're measuring

Assessment of pain severity

Timeframe: 12 months

Absences of swelling / fistulous tract

Timeframe: 12 months

Trial details

NCT IDNCT04989036

SponsorCairo University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2017-10-01

View on ClinicalTrials.gov More Pulp Exposure, Dental trials